Insulin-like growth factor-1 and dibutyryl CAMP induce differentiation and decrease opioid receptor binding activity...

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Neuroblastoma cells (N4TG1) are a model for studying neuronal development and function.
• Fibroblast growth factor (FGF), insulin, insulin-like growth factor-1 (IGF-1), and dibutyryl cAMP (Bt(2)cAMP) are known to influence cell behavior.

Purpose of the Study:

• To investigate the effects of FGF, insulin, IGF-1, and Bt(2)cAMP on N4TG1 cell proliferation, differentiation, opioid receptor binding, and proto-oncogene expression (fos, myc, ras).

Main Methods:

• N4TG1 neuroblastoma cells were treated with FGF, insulin, IGF-1, and Bt(2)cAMP.
• Cell proliferation was assessed by thymidine incorporation and cell counting.
• Neurite extension was observed as a marker of differentiation.
• Opioid receptor binding activity was measured.
• Proto-oncogene expression (fos, myc, ras) was analyzed using Northern blot and hybridization.

Main Results:

• IGF-1 and insulin increased cell proliferation, while Bt(2)cAMP inhibited it; FGF had no significant effect.
• Bt(2)cAMP and IGF-1 induced neurite-like process extension, indicating neuronal differentiation.
• IGF-1 and Bt(2)cAMP decreased delta-opioid receptor binding activity.
• FGF stimulated fos expression, but not myc or ras expression.
• IGF-1 and Bt(2)cAMP did not significantly alter fos, myc, or ras expression.

Conclusions:

• IGF-1 can induce both proliferation and differentiation in N4TG1 neuroblastoma cells.
• Proto-oncogene expression (fos, myc, ras) appears independent of IGF-1 and Bt(2)cAMP-induced differentiation and opioid receptor regulation in these cells.